Ji-Min Yoo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ji-Min Yoo has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Sung-Wan Kim
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
3 shared publications - Jae-Min Kim
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea
2 shared publications - Ju-Yeon Lee
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Republic of Korea
2 shared publications - Seunghyong Ryu
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
2 shared publications - Carolyn Seungyoun Moon
North London NHS Foundation Trust, London, United Kingdom
1 shared publication - Chan-Yeong Cho
Department of Psychiatry, Chonnam National University Medical School, Gwangju, Korea
1 shared publication
Latest Publications
- Open Access
- 31 October 2026
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 29 (2) , 83-99
Suicide Prevention in Patients With Schizophrenia Spectrum Disorders: Assessment and Integrated Interventions
Individuals with schizophrenia spectrum disorders have a higher risk of suicide than the general population. Suicide prevention is central to care for people with schizophrenia spectrum disorders. This narrative review integrates evidence on high-risk periods, therapeutic assessment, pharmacotherapy, psychosocial interventions, and continuity of care, with attention to implementation in Korea. Assessment should connect historical vulnerability, current modifiable factors, foreseeable changes, and available protective resources in an individualized formulation rather than rely on risk categories to predict suicide. Early illness and the period immediately after discharge warrant particular attention. Integrated care combines optimized pharmacotherapy, suicide-focused psychosocial interventions, early intervention services, and sustained case management. Evidence for improvements in suicidal ideation should be distinguished from evidence for reductions in attempts or deaths, and findings from other populations require cautious application. Hospital and community services should jointly plan transitions, confirm timely follow-up, and clarify responsibilities. Strengthening these arrangements, staff support, and implementation research may help translate assessment into sustained, coordinated care.
- 31 October 2026
- Published by Korean Society for Schizophrenia Research in Korean Journal of Schizophrenia Research
- Vol. 29 (2) , 83-99
Open AccessSuicide Prevention in Patients With Schizophrenia Spectrum Disorders: Assessment and Integrated Interventions
Individuals with schizophrenia spectrum disorders have a higher risk of suicide than the general population. Suicide prevention is central to care for people with schizophrenia spectrum disorders. This narrative review integrates evidence on high-risk periods, therapeutic assessment, pharmacotherapy, psychosocial interventions, and continuity of care, with attention to implementation in Korea. Assessment should connect historical vulnerability, current modifiable factors, foreseeable changes, and available protective resources in an individualized formulation rather than rely on risk categories to predict suicide. Early illness and the period immediately after discharge warrant particular attention. Integrated care combines optimized pharmacotherapy, suicide-focused psychosocial interventions, early intervention services, and sustained case management. Evidence for improvements in suicidal ideation should be distinguished from evidence for reductions in attempts or deaths, and findings from other populations require cautious application. Hospital and community services should jointly plan transitions, confirm timely follow-up, and clarify responsibilities. Strengthening these arrangements, staff support, and implementation research may help translate assessment into sustained, coordinated care.
- Open Access
- 25 January 2025
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 22 (1) , 110-116
The Role of Knowledge and Personal Experience in Shaping Stigma Associated With COVID-19 and Mental Illness
Objective Stigma influences perceptions of mental illness and novel diseases like coronavirus disease-2019 (COVID-19), often impeding healthcare access despite advancements in medical treatment. This study compares the stigma associated with COVID-19 and mental illness to identify factors that could help reduce stigma.Methods An online survey was conducted in May 2023 among 1,500 participants aged 19 to 65 in South Korea, using a panel from Embrain, an online survey service. The survey assessed stigma and distress related to COVID-19 and mental illness using a validated questionnaire. It collected demographic and clinical data, evaluated COVID-19-related stigma, fear, and knowledge, and measured prejudice and attitudes toward psychiatric treatment. Personality traits were assessed using the Big Five Inventory (BFI)-10. Factors significantly associated with stigma scores were entered into linear regression analysis.Results COVID-19-related stigma scores were significantly negatively correlated with knowledge of COVID-19 and positively correlated with fear of infection and age. Individuals with a history of COVID-19 infection had significantly lower scores on COVID-19-related stigma. Similarly, mental illness stigma was negatively correlated with knowledge of psychiatric treatment and positively correlated with age, as well as conscientiousness and neuroticism in the BFI. Personal experience with individuals with mental illness was associated with significantly lower stigma scores.Conclusion This study suggests that the mechanism-making stigma was similar in cases of traditional mental illness and a novel infectious disease. Both cognitive and experiential factors influence stigma. Educating the public about the disease and enabling interactions with affected individuals emerge as effective strategies for stigma reduction.
- 25 January 2025
- Published by Korean Neuropsychiatric Association in Psychiatry Investigation
- Vol. 22 (1) , 110-116
Open AccessThe Role of Knowledge and Personal Experience in Shaping Stigma Associated With COVID-19 and Mental Illness
Objective Stigma influences perceptions of mental illness and novel diseases like coronavirus disease-2019 (COVID-19), often impeding healthcare access despite advancements in medical treatment. This study compares the stigma associated with COVID-19 and mental illness to identify factors that could help reduce stigma.Methods An online survey was conducted in May 2023 among 1,500 participants aged 19 to 65 in South Korea, using a panel from Embrain, an online survey service. The survey assessed stigma and distress related to COVID-19 and mental illness using a validated questionnaire. It collected demographic and clinical data, evaluated COVID-19-related stigma, fear, and knowledge, and measured prejudice and attitudes toward psychiatric treatment. Personality traits were assessed using the Big Five Inventory (BFI)-10. Factors significantly associated with stigma scores were entered into linear regression analysis.Results COVID-19-related stigma scores were significantly negatively correlated with knowledge of COVID-19 and positively correlated with fear of infection and age. Individuals with a history of COVID-19 infection had significantly lower scores on COVID-19-related stigma. Similarly, mental illness stigma was negatively correlated with knowledge of psychiatric treatment and positively correlated with age, as well as conscientiousness and neuroticism in the BFI. Personal experience with individuals with mental illness was associated with significantly lower stigma scores.Conclusion This study suggests that the mechanism-making stigma was similar in cases of traditional mental illness and a novel infectious disease. Both cognitive and experiential factors influence stigma. Educating the public about the disease and enabling interactions with affected individuals emerge as effective strategies for stigma reduction.
- Open Access
- 10 October 2024
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 23 (1) , 155-160
Educational Level Modifies the Relationship between Standard Deviation of NN Intervals and Post-traumatic Stress Disorder Development over Two-years
Ji Min Yoo, Ju-Wan Kim, Hee-Ju Kang, Hyunseok Jang, Jung-Chul Kim, Ju-Yeon Lee, Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim. Clin Psychopharmacol Neurosci 2025;23:155-60. https://doi.org/10.9758/cpn.24.1210
- 10 October 2024
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 23 (1) , 155-160
Open AccessEducational Level Modifies the Relationship between Standard Deviation of NN Intervals and Post-traumatic Stress Disorder Development over Two-years
Ji Min Yoo, Ju-Wan Kim, Hee-Ju Kang, Hyunseok Jang, Jung-Chul Kim, Ju-Yeon Lee, Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim. Clin Psychopharmacol Neurosci 2025;23:155-60. https://doi.org/10.9758/cpn.24.1210